Switch to Dark

Pricing

Learn

MRK - Merck & Co Inc

386

$114.90

$0.69 (0.609%)

3/20/26, 3:35 PM

Score

3.79/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Income Statement Summary

Metrics

KPIs

View as %

Merck & Co Inc

Stock Unlock

Legend	CAGR	Total Change	Average	Median	Low	High	Latest
Total Revenue	7.51%	5.61%	$16.25B	$16.10B	$15.53B 2025-03-31	$17.28B 2025-09-30	$16.40B 2025-12-31

Operating Expenses	14.59%	10.81%	$6.57B	$6.64B	$6.17B 2025-03-31	$6.84B 2025-12-31	$6.84B 2025-12-31

Net Interest Income Expense	--	-313.73%	-$294.00M	-$209.00M	-$844.00M 2025-12-31	$86.00M 2025-09-30	-$844.00M 2025-12-31

Income Tax Expense	-53.69%	-44.01%	$701.25M	$694.50M	$458.00M 2025-12-31	$958.00M 2025-09-30	$458.00M 2025-12-31

Cost of Goods Sold (COGS)	-2.31%	-1.74%	$3.49B	$3.42B	$3.32B 2025-12-31	$3.78B 2025-09-30	$3.32B 2025-12-31

Income Statement

Balance Sheet

Cash Flow

Metrics

KPIs

% Change

Colors

#'s in thousands USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31 Get more features by creating a free Stock Unlock account: 2 portfolios, 5 positions per portfolio 2 watchlists, up to 10 tickers per watchlist More screener searches See full feature list	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Total Revenue	16,400,000	17,276,000	15,806,000	15,529,000	42,069,000	7470975	7444819	6174973	5238047	3608464	1394741	8126397	4795751	7819542	8221721	1059669	4238012	4259403
Cost of Goods Sold (COGS)	3,324,000	3,783,000	3,457,000	3,383,000	42,069,000	1616641	7702003	4989785	2177069	1722224	6724027	6485078	8209764	6320508	7080534	6693545	844994	3274229
Gross Profit	13,076,000	13,493,000	12,349,000	12,146,000	42,069,000	8230418	4213332	106953	7124863	8996498	1962421	5213050	5457452	1216048	1543356	4305836	6891903	9300064
Operating Expenses	6,840,000	6,634,000	6,643,000	6,173,000	42,069,000	1492262	2487619	1423590	6942469	583039	6407032	8499471	6242716	1690570	5222352	3117606	1183685	8166650
Research & Development	3,992,000	4,001,000	3,995,000	3,621,000	42,069,000	729248	6225574	4327563	4498307	8979173	690333	3807225	454247	8628329	7178997	4500118	6399438	8787388
Selling, General & Administrative Expenses	2,848,000	2,633,000	2,648,000	2,552,000	42,069,000	470087	4423728	280013	7605166	386230	9695839	2237364	2447476	630156	8971504	2944391	5880480	7061665
Operating Income or Loss	6,236,000	6,859,000	5,706,000	5,973,000	42,069,000	1212142	8243350	1094995	8549775	8952525	8702720	6396904	9795613	3244104	5548932	6365333	3688536	156081
Interest Expense	-412,000	-327,000	-305,000	-313,000	42,069,000	8118066	9397665	4514355	6360886	3965785	6977461	4312350	9030226	8542514	1857268	4309821	6450941	5502010
Net Interest Income Expense	-844,000	86,000	-214,000	-204,000	42,069,000	7709513	1042257	7433837	2509865	4558434	4770381	7652998	9427491	9174738	9151104	5790478	3538300	5993916
Non-Recurring Items	-2,384,000	-352,000	-714,000	-105,000	42,069,000	1807507	4088633	8149436	7114175	2764833	2197094	8271881	3484646	7348646	1917028	961067	9716647	7508464
Total Other Income/Expense Net	412,000	152,000	221,000	239,000	42,069,000	8647930	582550	2764210	5934070	331337	8840141	1317161	491350	3357780	165417	8681570	2848461	6456121
Income Before Tax	3,420,000	6,745,000	4,999,000	5,903,000	42,069,000	3517056	1051317	9216723	4621467	1997991	7172428	1598972	9940668	7018164	2806661	177807	523696	2775316
Income Tax Expense	458,000	958,000	571,000	818,000	42,069,000	7953216	1590260	4140053	7163963	1508052	6879332	5385745	7635882	983383	6629146	7804893	1626246	6913176
Earnings	2,963,000	5,785,000	4,427,000	5,079,000	42,069,000	8646676	2980017	9593413	957206	2437382	4207013	4273220	1435190	5222936	9213083	9025773	388725	1552473
Adjusted Net Income	579,000	5,433,000	3,713,000	4,974,000	42,069,000	5986253	8018274	2790697	2950421	4606732	8023002	2528357	4811764	2965284	2455397	2303136	8628046	1089400
Net Income After Taxes	2,962,000	5,787,000	4,428,000	5,085,000	42,069,000	7260939	1921736	5221954	1999747	3528339	1995394	5969434	6972382	552374	3257771	6797929	6337607	4579938
Diluted Shares Outstanding	2,488,000	2,498,000	2,513,000	2,531,000	42,069	4409345	9666033	8294840	7795718	9906490	5685746	1797914	5817246	7594635	6409946	754379	1630783	2639751
Diluted EPS	1.19	2.32	1.76	2.01	42,069	8059743	2163522	8256674	4580253	181550	7096779	31282	2463351	5231213	2758192	6674130	4940571	4826080
Adjusted EPS	0.23	2.17	1.48	1.97	42,069	5025645	493693	4837630	5016647	2921486	8876910	2960598	1756281	2931183	2141673	3224520	6111547	5192991
EBITDA	8,702,000	8,013,000	6,825,000	7,072,000	42,069,000	2012876	4197218	1797828	4621710	5384646	6629649	2362809	2748784	317398	3665133	3501625	932548	5393001